Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone SR capsules for opioid-induced constipation in persistent non-cancer pain
2009-009377-10Phase 2Completed
- Sponsor
- SLA Pharma
- Start
- Apr 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in opioid-induced constipation (OIC) and constipation comparing Naloxone SR capsules with Placebo (2 arms). Primary endpoint: Incidence and severity of treatment-emergent adverse events. Started Apr 2009; status: completed.
02
Drugs
naloxone
03
Conditions
opioid-induced constipation (OIC)constipation
Beyond the preview
Go deeper on 2009-009377-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009377-10.